Esteruelas G, Ettcheto M, Haro I, Herrando-Grabulosa M, Gaja-Capdevila N, Gomara MJ, Navarro X, Espina M, Souto EB, Camins A, García ML, Sánchez-López E.
A combinatory therapy of metformin and dexamethasone reduces the foreign body reaction to intraneural electrodes.
Int J Nanomedicine 2025, 20:2273-2288.
doi: 10.2147/IJN.S479819.

Moreno-Martinez L, Gaja-Capdevila N, Mosqueira-Martín L, Herrando-Grabulosa M, Rodriguez-Gomez L, Gonzalez-Imaz K, Calvo AC, Sagartzazu-Aizpurua M, Moreno-García L, Fuentes JM, Acevedo-Arozena A, Aizpurua JM, Miranda JI, López de Munain A, Vallejo-Illarramendi A, Navarro X, Osta R, Gil-Bea FJ.
Novel FKBP prolyl isomerase 1A (FKBP12) ligand promotes functional improvement in SOD1G93A amyotrophic lateral sclerosis (ALS) mice.
Br J Pharmacol 2025, Feb 13.
doi: 10.1111/bph.17448.

Francos-Quijorna I, Lopez-Gonzalez N, Caro-Canton M, Sanchez-Fernandez A, Hernandez-Mir G, López-Vales R.
Lack of effects of Resolvin D1 after spinal cord injury in mice.
Exp Neurol 2025, 388:115226
doi: 10.1016/j.expneurol.2025.115226.

Manich G, Pérez B, Penas C, Dantas AP, Coutinho J, Sánchez-Bernadó P, García-Aranda J, Fraile-Ramos J, Benseny- Cases N, Martín-Mur B, Esteve-Codina A, Rodríguez-Rovira I, Giménez-Llort L, Egea G, Jiménez-Altayó F.
Sex- and age-dependent neurovascular abnormalities linked to neuroinflammation lead to exacerbated post-ischemic brain injury in Marfan syndrome mice.
Redox Biology 2025, 83:103662.
doi: 10.1016/j.expneurol.2025.115226.

Turrin G, Crugeiras J, Bisquoli C, Barboni D, Catani M, Rodríguez-Meana B, Boaretto R, Albicini M, Caramori S, Trapella C, Stieglitz T, Baslan Y, Karlsson-Fernberg H, Narvaez-Chicaiza FL, Marchini E, Cavazzini A, López-Vales R, Asplund M, Navarro X, Carli S.
Covalent binding of dexamethasone to polyimide improves biocompatibility of neural implantable devices.
Adv HealthCare Mater 2025, 17:e2405004.
doi: 10.1002/adhm.202405004.

Sánchez-Ventura J, Schardien KA, Fortino T, Zholudeva LV, Lane MA, Udina E.
Perineuronal net changes reveal a distinct right and left spinal phrenic circuit.
J Neurotrauma 2025, May 28.
doi: 10.1089/neu.2024.0597.

Besora S, Garcilazo-Reyes Y, Velasco R.
Methotrexate-induced neurotoxicity in oncology: Current issues for a classic drug.
J Neurol Sci 2025, 473:123514.
doi: 10.1016/j.jns.2025.123514.

Palomés-Borrajo G, Navarro X, Penas C.
Histone acetylation in central and peripheral nervous system injuries and regeneration: epigenetic dynamics and therapeutic perspectives.
Int J Mol Sci 2025, 26(13):6277.
doi: 10.3390/ijms26136277.

Masegosa VM, Fritz E, Corvalan D, Rojas F, Garcés P, Navarro X, Bloms-Funke P, van Zundert B, Herrando-Grabulosa M.
Novel dual mechanism GRT-X agonist acting on Kv7 potassium channel/translocator protein receptor prevents motoneuron degeneration following exposure to mouse and human amyotrophic lateral sclerosis/frontotemporal dementia astrocyte-conditioned media.
ACS Chem Neurosci 2025, 16(15):2887-2900.
doi: 10.1021/acschemneuro.5c00197.

Negro-Demontel L, Evans F, Cawen A, Fitzpatrick Z, Mason HD, Ali D, Lopez-Vales R, Lago N, Peluffo H.
CD300f enables microglial damage sensing, efferocytosis, and apoptotic cell metabolization after brain injury.
Brain Behav Immun 2025 :106105.
doi: 10.1016/j.bbi.2025.106105.

Verdés S, Navarro X, Bosch A.
Targeting Amyotrophic Lateral Sclerosis with gene therapy: from silencing genes to enhancing neuroprotection.
Hum Gene Ther 2025, 36 (17-18): 1173-1198.
doi: 10.1177/10430342251372898.

Ivorra A, Ausín T, Becerra-Fajardo L, Del Ama AJ, Minguillón J, García-Moreno A, Aguiló J, Barroso FO, Bijnens B, Camara O, Capdevila S, Fernandez RC, Davalos RV, Divoux JL, Eladly A, Farina D, Hombravella CG, López RG, Gonzalez CA, Grífols J, Maglietti F, Malik S, Maor E, Marshall G, Yus BM, Mir LM, Moreno JC, Navarro X, Noguera N, Ozaita A, Piella G, Pons JL, Quesada R, Rivera-Gil P, Rubinsky B, Garcia AR, Ruiz-Vargas A, Sánchez Sánchez M, Schneider-Ickert A, Shu T, Sanz RV, Zhang B, Revuelta G.
The biomedical engineer’s pledge: overview and context.
Med Biol Eng Comput 2025 Sep 24.
doi: 10.1007/s11517-025-03443-6

Pannunzio B, Cawen A, Evans F, Lopez-Vales R, Peluffo R, Lago N.
CD200R1 modulates myelin phagocytosis and spleen response following spinal cord injury.
Scientific Reports 2025, 15 (1): 41013.
doi: 10.1038/s41598-025-24827-6.

Alemany M, Bruna J, Yuste VJ.
Reaching the point-of-no-return: The cornerstone of glioblastoma treatment?
Neurooncol Adv 2025, 7(1):vdaf174.
doi: 10.1093/noajnl/vdaf174.

Velasco R, Abad-Inchaurrondo I, Sureda A.
CAR-T cell-associated neurotoxicity during therapy of hematologic malignancies: incidence, clinical features, predictive biomarkers and management measures.
Leuk Lymphoma 2025, 66 (9): 1557-1569.
doi: 10.1080/10428194.2025.2502810.

Díaz‑Pérez A, Alvarez de Eulate N, Masvidal‑Codina E, Illa X, Navarro X , Guimerà‑Brunet, A, Jiménez‑Altayó F, Penas, C.
Cortical spreading depolarizations in stroke: Mechanisms, neuroprotective interventions, and monitoring techniques.
GeroScience 2025, Nov 26.
doi: 10.1007/s11357-025-01988-w.

Ciotti F, Cimolato A, Gozzi N, Palopoli P, Brugnoli L, Katic-Secerovic N, Gallivan R, Shokurov A, Menon C, Weichart J, Delgado-Martinez I, Song W, Zanos S, Navarro X, Raspopovic S.
From in-silico optimized microfabrication to experimental validation: engineering a tridimensional epi-intraneural interface.
Adv Funct Mater 2025, e22367.
doi: 10.1002/adfm.202522367.